share_log

Chardan Capital Initiates Coverage On Anixa Biosciences With Buy Rating, Announces Price Target of $8

Chardan Capital Initiates Coverage On Anixa Biosciences With Buy Rating, Announces Price Target of $8

查丹資本以購買評級啟動 Anixa 生物科學的覆蓋範圍,宣布目標價格為 8 美元
Benzinga Real-time News ·  2022/12/23 05:41

Chardan Capital analyst Matthew Barcus initiates coverage on Anixa Biosciences (NASDAQ:ANIX) with a Buy rating and announces Price Target of $8.

Chardan Capital分析師馬修·巴庫斯以買入評級啟動對Anixa Biosciences(納斯達克:ANIX)的報道,並宣佈目標價為8美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論